FGF23 NM_020638.3(FGF23):c.211A>G (p.Ser71Gly)

CI-VAR-00005444Explore in graph →p.Ser71GlyNM_020638.3:c.211A>GClinVar 5027 rs104894342

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
5027	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	1	Tumoral calcinosis, hyperphosphatemic, familial, 1; Tumoral calcinosis, hyperphosphatemic, familial, 2; Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome; Autosomal dominant hypophosphatemic rickets	germline	7	Jun 13, 2024	clinvar